A detailed history of Aquatic Capital Management LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Aquatic Capital Management LLC holds 17,300 shares of VYGR stock, worth $97,918. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,300
Previous 21,300 18.78%
Holding current value
$97,918
Previous $168,000 39.88%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.77 - $9.27 $23,080 - $37,080
-4,000 Reduced 18.78%
17,300 $101,000
Q2 2024

Aug 14, 2024

BUY
$7.42 - $10.54 $158,046 - $224,501
21,300 New
21,300 $168,000
Q4 2023

Feb 14, 2024

BUY
$6.28 - $8.81 $6,908 - $9,691
1,100 New
1,100 $9,000
Q3 2022

Nov 14, 2022

BUY
$5.57 - $7.47 $11,697 - $15,687
2,100 Added 1050.0%
2,300 $14,000
Q2 2022

Aug 15, 2022

BUY
$4.82 - $10.09 $964 - $2,018
200 New
200 $1,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $219M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.